Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,593 Jan 1 – Oct 24, 2026
- Disclosed funding
- $297.4B 3619 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| F Provides AI platform for insurance brokerages to modernize workflows | $25M | Seed+Series AUndisclosed | Fintech | United States | Investors | |
| AA Arctis AICompany profile Arctis AI builds software agents that help construction teams find projects, assess tenders, compare bids and review contracts. Arctis AI builds software agents that help construction teams find projects, assess tenders, compare bids and review contracts. | $1M | Undisclosed | Proptech | Germany | Investors | |
| NA Provides a privacy-first platform for outcome-driven college counseling | $3.2M | Seed | Edtech | United States | Investors | |
| G GridlineCompany profile Provides a turnkey alternatives management platform for private market investing Provides a turnkey alternatives management platform for private market investing | $18.5M | Series A | Fintech | United States | Investors | |
| C ChamelioCompany profile Chamelio provides AI contract review, negotiation and legal-workflow tools for in-house legal teams. Chamelio provides AI contract review, negotiation and legal-workflow tools for in-house legal teams. | $10M | Seed | Enterprise software | United States | Investors | |
| M Automates SOX testing and internal audit workflows with agentic AI | $4.2M | Seed | AI | United States | Investors | |
| SM Develops real-time microscopy for surgical procedures | €20M | Undisclosed | Healthtech | Belgium | Investors | |
| P Provides agentic AI for accounts receivable automation in B2B finance | $5M | Seed | AI | United Kingdom | Investors | |
| A AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $24M | Series C second closeSeries C+ | Biotech | United States | Investors | |
| FA Provides AI observability and security platform for enterprises | $30M | Series CSeries C+ | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
158rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds8led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →